Literature DB >> 24952510

Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.

Yanru Fan1, Xuedong Song, Hongfei Du, Chunli Luo, Xiaorong Wang, Xue Yang, Yin Wang, Xiaohou Wu.   

Abstract

The purpose of this study was to explore new tumor suppressor microRNA in bladder cancer and to conduct functional analysis of its suppressive role. To investigate the expression of miR-29c, qRT-PCR was used in 30 pairs of bladder cancer tissues and normal tissues (adjacent bladder tissue samples). The expression of miR-29c was down regulated in bladder cancer tissues compared with normal tissues. Also, the low-level expression of miR-29c was associated with tumor stage (P = 0.002), and ectopic over-expression of miR-29c in T24 cells can significantly inhibit cell proliferation, decrease motility, suppress the G1/S cell cycle transition and induce apoptosis. Furthermore, it could cause a decrease in AKT and GSK-3β phosphorylation. While LY294002 reduced the protein level of pAKT, the over-expression of miR-29c can further decrease its level in T24 cells pretreated with LY294002. Our study also indicated that the proliferation inhibition of T24 may take place via AKT-GSK3β pathway. Thus, miR-29c could be an active player in disease state of bladder cancer and it may be a promising tumor suppressor in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24952510     DOI: 10.1007/s12032-014-0065-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  31 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

3.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Authors:  Jian-Jun Zhao; Jianhong Lin; Tint Lwin; Hua Yang; Jianping Guo; William Kong; Sophie Dessureault; Lynn C Moscinski; Dorna Rezania; William S Dalton; Eduardo Sotomayor; Jianguo Tao; Jin Q Cheng
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

4.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

5.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 6.  Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Authors:  Margaret A Knowles; Fiona M Platt; Rebecca L Ross; Carolyn D Hurst
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

7.  miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development.

Authors:  W Wei; H-B He; W-Y Zhang; H-X Zhang; J-B Bai; H-Z Liu; J-H Cao; K-C Chang; X-Y Li; S-H Zhao
Journal:  Cell Death Dis       Date:  2013-06-13       Impact factor: 8.469

8.  miR-379 regulates cyclin B1 expression and is decreased in breast cancer.

Authors:  Sonja Khan; Cathy L Brougham; James Ryan; Arisha Sahrudin; Gregory O'Neill; Deirdre Wall; Catherine Curran; John Newell; Michael J Kerin; Roisin M Dwyer
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

9.  Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).

Authors:  Ranlu Liu; Jing Li; Zhigang Teng; Zhihong Zhang; Yong Xu
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

Review 10.  The microRNA (miRNA): overview of the RNA genes that modulate gene function.

Authors:  Shao-Yao Ying; Donald C Chang; Shi-Lung Lin
Journal:  Mol Biotechnol       Date:  2007-11-13       Impact factor: 2.695

View more
  14 in total

1.  Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.

Authors:  Wang Xin Yuan; Yang Xi Gui; Wang Na Na; Jiang Chao; Xigui Yang
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

2.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

3.  MicroRNA-29c/PTEN pathway is involved in mice brain development and modulates neurite outgrowth in PC12 cells.

Authors:  Hongjun Zou; Ya Ding; Weifeng Shi; Xu Xu; Aihua Gong; Zhijian Zhang; Jinbo Liu
Journal:  Cell Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.046

4.  hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC.

Authors:  Shitong Zhang; Jianjun Jin; Xiaoxiao Tian; Lijuan Wu
Journal:  Oncotarget       Date:  2017-11-10

Review 5.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

6.  Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.

Authors:  Naiqiang Zhu; Jingyi Hou; Yuanhao Wu; Jinxin Liu; Geng Li; Wenjia Zhao; Guiyun Ma; Bin Chen; Youxin Song
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1.

Authors:  Yebin Lu; Juanjuan Hu; Weijia Sun; Shengyu Li; Shuangya Deng; Ming Li
Journal:  Onco Targets Ther       Date:  2015-12-30       Impact factor: 4.147

8.  Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2016-05-19       Impact factor: 5.923

9.  CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.

Authors:  Roberta Zini; Paola Guglielmelli; Daniela Pietra; Elisa Rumi; Chiara Rossi; Sebastiano Rontauroli; Elena Genovese; Tiziana Fanelli; Laura Calabresi; Elisa Bianchi; Simona Salati; Mario Cazzola; Enrico Tagliafico; Alessandro M Vannucchi; Rossella Manfredini
Journal:  Blood Cancer J       Date:  2017-12-08       Impact factor: 11.037

Review 10.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.